	Corrigendum to "Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-GuÃ©rin (BCG) in BCG-naÃ¯ve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials" [Eur. Urol. (2025)]. Eur Urol Scilipoti P, Zaurito P, Longoni M, Colecchia M, Montorsi F, Salonia A, Mercinelli C, Maiorano B, Necchi A, Briganti A, Moschini M. PMID: 41708452 [PubMed - as supplied by publisher]
	MRI-Based Habitat Radiomics for Predicting Postoperative Recurrence in Nonmetastatic Clear Cell Renal Cell Carcinoma. Acad Radiol Yi S, Jia T, Bai X, Kang H, Zhao J, Liu B, Li C, Wen X, Xu H, Ning X, Liu H, Cui M, Zhou S, Ma Y, Xie L, Zhao H, Ma X, Wang H. PMID: 41708388 [PubMed - as supplied by publisher]
	Risk Factor of Persistent Hypotension Associated with 5-Aminolevulinic Acid: A Single-Institution Retrospective Study. Biol Pharm Bull Okada N, Kimura H, Ozaki M, Tamura M, Ochi F, Sasaki T, Takimoto T, Kitahara T. PMID: 41708090 [PubMed - indexed for MEDLINE]
	To Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer Database. Int J Urol Kobayashi S, Shiota M, Onozawa M, Taguchi S, Yamamoto Y, Sakamoto S, Kawai T, Nakagawa T, Hinotsu S, Eto M, Kume H, Japan Study Group of Prostate Cancer (J. PMID: 41708074 [PubMed - indexed for MEDLINE]
	Molecular insights for the tumor suppressor role of SPOP in prostate cancer. Biochim Biophys Acta Rev Cancer Yan P, Xue X, Hou T, Wang J, Jiang W, Wang Z, Inuzuka H, Wei W. PMID: 41707797 [PubMed - as supplied by publisher]
	Optimising on-treatment review schedules: A narrative review of acute toxicities in ultra-hypofractionated stereotactic ablative body radiotherapy (SABR) for localised prostate cancer. Radiography (Lond) McKenna G, Flood T. PMID: 41707610 [PubMed - as supplied by publisher]
	Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med Vulsteke C, Adra N, Danchaivijitr P, Sabadash M, Rodriguez-Vida A, Zhang Z, Atduev V, Göger YE, Rausch S, Kang SH, Loriot Y, Bedke J, Galsky MD, O'Donnell PH, von Amsberg G, Alimohamed N, Sulimka G, Gupta S, Paramonov V, Nakane K, Mihm M, Meng C, Huang CD, Ramamurthy C, Homet Moreno B, Ullén A, KEYNOTE-905/EV-303 Investigators. PMID: 41707170 [PubMed - as supplied by publisher]
	Not all progression is equal. Cancer Venkateswaran S, Mantena RV, Willmann J, Zhang YH, Dee EC, Iyengar P. PMID: 41707059 [PubMed - indexed for MEDLINE]
	Integrating machine learning and mendelian randomization for identifying genetic biomarkers in bladder cancer: implications for early diagnosis and targeted therapies. Int J Surg Xu C, Dong Y, Li J, Liao X, Zhang C, Lv C, Li C, Liu Y, Yao L, Zhou L. PMID: 41706814 [PubMed - as supplied by publisher]
	Explore the potential mechanisms between ertugliflozin and kidney cancer through bioinformatics analysis and Mendelian randomization study. Int J Surg Xu B, Xiang P, Yang X, Zhang T, Liu Y, Tang F, He Z, Zhou J. PMID: 41706624 [PubMed - as supplied by publisher]
	Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial. JAMA Cardiol Patel SA, Yadalam AK, van Assen M, Cantu SM, Onnis C, Zheng B, Koo A, Goyal S, Liu Y, Liu C, Sebastian NT, Dhere VR, Hershatter BW, Patel PR, Chaudagar K, Stillman AE, De Cecco CN, Sanda MG, Jani AB, Mandawat A. PMID: 41706486 [PubMed - as supplied by publisher]
	Palliative Intra-Arterial Chemotherapy Without Radiotherapy for Elderly Patients With Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Comparison With Radical Cystectomy and Best Supportive Care. Int J Urol Kusano S, Tobu S, Yukimoto M, Yamaguchi Y, Maeda A, Kakinoki Y, Kakinoki H, Kawasaki M, Yamaguchi K, Egashira Y, Noguchi M. PMID: 41705566 [PubMed - indexed for MEDLINE]
	Incidental prostate cancer following surgery for benign prostatic hyperplasia: a cohort study. Arch Ital Urol Androl Pedrosa R, Lorigo J, Guerra AJ, Figueiredo B, Quaresma V, Eliseu M, Temido P, Figueiredo A. PMID: 41705465 [PubMed - as supplied by publisher]
	Soluble immune checkpoint proteins as predictive biomarkers for lymph node metastases in penile cancer. Front Immunol Glombik D, Carlsson J, Kirrander P, Davidsson S. PMID: 41705256 [PubMed - indexed for MEDLINE]
	Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting nivolumab-responsive renal cell carcinoma. Front Immunol Wang M, Dong W, Chen J, Wu P, Wang Y, Zhang X, Cao Y, Wang Z, Zhong Z, Zhong Y. PMID: 41705252 [PubMed - indexed for MEDLINE]
	Tumor-associated neutrophils in renal cell carcinoma. Front Immunol Kovaleva OV, Sinyov VV, Rashidova MA, Malashenko OS, Gratchev A. PMID: 41705247 [PubMed - indexed for MEDLINE]
	Predictive value of peripheral blood immune markers for castration-resistant prostate cancer development after endocrine therapy. Front Oncol Li F, Cui L, Zhang G, Hao J. PMID: 41704610 [PubMed]
	Developing an automatic decision-assistance tool to choose proton/photon radiotherapy for patients with prostate cancer. J Appl Clin Med Phys Li M, Shen L, Chen X, Li G, Ding J, Men K, Yi J, Dai J. PMID: 41704219 [PubMed - indexed for MEDLINE]
	Real-World Comparative Study of Apalutamide Versus Bicalutamide in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer. Int J Urol Takahashi H, Fukuokaya W, Muramoto K, Katsumi K, Urabe F, Mori K, Yanagisawa T, Tashiro K, Kimura T, JIKEI. PMID: 41704150 [PubMed - indexed for MEDLINE]
	From Natural Limonoids to a Rationally Designed Derivative: Facilitating the Study of Anti-Adenocarcinoma Potential and Mechanisms Through Solubility Enhancement. Arch Pharm (Weinheim) Guo J, Luo X, Chen Z, Zhang X, Li D, Yu H, Gong Y, Bi Y, Li H. PMID: 41703769 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 176101

Page 1 of 8806



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy